Soft Gel Encapsulation Machine Market Size, Share, and Growth Forecast 2026 - 2033

The global soft gel encapsulation machine market is expected to reach US$ 120.9 million in 2026 and is projected to reach US$ 165.6 million by 2033, expanding at a CAGR of 4.6% between 2026 and 2033. Rising demand for nutraceuticals and easy-to-swallow dosage forms is encouraging pharmaceutical and supplement manufacturers to expand soft gel production capacity.

Manufacturers are replacing older manual and semi-automatic equipment with fully automatic machines to increase throughput and reduce labor requirements. Growing contract manufacturing activity in Asia Pacific, along with steady demand from pharmaceutical, cosmetic, and food applications, is further supporting equipment sales through 2033.

Drivers - Rising Demand for Nutraceuticals and Dietary Supplements

Growing consumer focus on preventive health is increasing demand for soft gel vitamins, omega-3 supplements, and probiotics worldwide. Soft gels offer taste masking, ease of swallowing, and efficient delivery of certain active ingredients, supporting their use across a growing range of nutraceutical products. This shift is encouraging nutraceutical brands and contract manufacturers to invest in dedicated encapsulation capacity. Rising sales of joint health, immunity, and beauty-from-within soft gel products are further supporting demand for new production equipment.

Supplement companies are expanding their soft gel portfolios across multiple health categories, increasing demand for rotary die and fully automatic machines suited to larger batch sizes. Ingredient innovation, including plant-based alternatives to traditional gelatin, is also encouraging equipment upgrades to accommodate different shell formulations. As nutraceutical production and exports expand across Asia Pacific and North America, machine suppliers are receiving increased demand from mid-size and large-scale manufacturers seeking flexible, high-throughput production lines.

Pharmaceutical Industry's Shift Toward Patient-Friendly Dosage Forms

Pharmaceutical companies are increasingly selecting soft gel capsules for drugs that are challenging to formulate as conventional tablets, including oily and poorly soluble compounds. Soft gels can improve ease of administration and patient compliance, particularly among elderly patients and children who experience difficulty swallowing semi-solid dosage forms. This preference is increasing demand for precision encapsulation machines capable of maintaining consistent fill weights and shell thickness across large production runs.

Generic drug manufacturers and contract development and manufacturing organizations are adding soft gel production capabilities to broaden their dosage form offerings and meet customer specifications. Rising outsourcing of fill-finish operations to specialized manufacturers is further increasing utilization of high-speed rotary die equipment. Pharmaceutical companies are also replacing older machines to meet evolving quality, hygiene, and production requirements, supporting replacement demand alongside capacity expansion across generic and branded drug facilities.

Restraints - High Capital Investment and Machine Complexity

Soft gel encapsulation machines require significant upfront investment, limiting adoption among small and newly established manufacturers. Fully automatic rotary die systems involve precision engineering, temperature-controlled gelatin handling, and integrated drying systems, which increase equipment costs. This financial barrier can slow capacity expansion among smaller nutraceutical and pharmaceutical producers, particularly in developing markets where access to capital is more constrained.

Beyond the initial purchase cost, these machines require skilled operators and regular maintenance to manage gelatin ribbon consistency, fill accuracy, and drying conditions. Facilities often require controlled production environments and climate management to protect gelatin shells from humidity-related defects, adding to installation and operating costs. Smaller manufacturers frequently rely on contract encapsulation services instead of purchasing equipment directly, limiting machine sales among lower-volume producers in price-sensitive markets.

Availability of Alternative Encapsulation and Dosage Technologies

Hard gelatin capsules, tablets, and alternative formats such as liquid-filled capsules and sachets provide manufacturers with competing dosage options. Nutraceutical and generic drug companies often select these formats when formulation requirements, product stability, or cost targets make soft gels less suitable. This competition limits the pool of manufacturers investing directly in soft gel encapsulation equipment, particularly for formulations that do not require lipid-based or oil-based delivery.

Advances in tablet coating and powder-filled capsule technologies are addressing some of the taste-masking and swallowing requirements traditionally associated with soft gels. Vegetarian and vegan product preferences are also encouraging brands to explore delivery formats that avoid animal-derived gelatin. As formulation technologies continue expanding, manufacturers are increasingly evaluating soft gel equipment alongside alternative production systems when allocating capital toward new dosage-form capacity.

Opportunities - Expanding Contract Manufacturing and Nutraceutical Outsourcing

Rising outsourcing of nutraceutical and pharmaceutical production is creating opportunities for soft gel encapsulation machine suppliers. Brand owners are increasingly relying on contract manufacturers to manage production, allowing them to focus on product development, marketing, and distribution. This trend is encouraging contract manufacturing organizations to invest in higher-capacity, fully automatic machines capable of producing multiple client formulations across shared production lines.

Growing demand from small and mid-size supplement brands without dedicated manufacturing facilities is expanding the customer base for contract encapsulation services. Contract manufacturers are responding by adding flexible equipment capable of switching between pharmaceutical, nutraceutical, and cosmetic soft gel formats. This flexibility is becoming an important purchasing consideration, encouraging equipment suppliers to develop modular systems suited to multi-product production environments.

Technological Advancements in Automation and Digital Monitoring

Newer soft gel encapsulation machines are incorporating digital monitoring, automated fill-weight control, and real-time defect detection to improve production consistency and reduce material waste. These capabilities are encouraging manufacturers to replace older mechanical systems with more automated equipment. Buyers are increasingly prioritizing machines that integrate with plant-wide data systems to support quality monitoring, batch tracking, and regulatory documentation across pharmaceutical and nutraceutical production lines.

Equipment manufacturers are investing in servo-driven dosing pumps, automated gelatin ribbon controls, and touchscreen interfaces to improve process control and reduce operator training requirements. Growing emphasis on batch traceability is also supporting demand for machines with integrated data logging and monitoring capabilities. As automation technologies become more accessible, mid-size manufacturers are gaining greater access to advanced equipment, expanding the addressable market for next-generation soft gel encapsulation systems.

Which Machine Type Leads the Soft Gel Encapsulation Machine Market?

Rotary die encapsulation machines represent the leading machine type segment, holding around 35% market share in 2026, supported by high-speed, continuous production and consistent shell thickness. Pharmaceutical and nutraceutical manufacturers favor rotary die systems for large-batch production because they combine precise fill accuracy with lower per-unit manufacturing costs. Their compatibility with a wide range of gelatin formulations and fill materials further supports adoption across established production facilities. Proven process reliability also enables repeatable output and consistent product quality across extended production cycles.

Fully automatic machines are the fastest-growing machine type, driven by manufacturers seeking to reduce manual intervention and labor dependency. Rising demand for consistent product quality, faster changeovers, and integration with digital monitoring systems is accelerating adoption. Contract manufacturers expanding multi-client production are increasingly selecting fully automatic lines to manage varied product schedules and production volumes. These systems also support tighter production timelines, process consistency, and quality documentation requirements. Increasing automation is therefore supporting broader adoption across pharmaceutical and nutraceutical manufacturing facilities.

Capacity Insights

Medium-scale is the leading capacity segment, holding about 42% share of the market in 2026, supported by its suitability for contract manufacturers and mid-size nutraceutical producers balancing production flexibility with output requirements. These systems allow manufacturers to serve multiple product lines without the space and capital requirements associated with large-scale installations. Their moderate footprint and operating costs make them practical for facilities producing pharmaceutical and nutraceutical soft gels across varied batch sizes. This capacity range also enables producers to adjust production volumes according to changing customer orders and market demand.

Large-scale is the fastest-growing capacity segment, driven by expanding contract manufacturing volumes and rising nutraceutical exports. Manufacturers increasing production to meet growing demand are investing in high-throughput lines that reduce per-unit costs at larger volumes. Growing private-label supplement production and consolidation among nutraceutical manufacturers are further supporting demand for larger, continuous-output encapsulation systems. Higher production requirements are encouraging manufacturers to expand capacity while maintaining consistent process efficiency across longer production runs and larger orders.

Which Application Leads the Soft Gel Encapsulation Machine Market?

The pharmaceuticals application segment is expected to lead the market, holding the largest share of 58% in 2026, supported by the established use of soft gels for vitamins, pain relief products, and oil-based drug formulations requiring precise dosing. Regulatory requirements for consistent fill accuracy and shell integrity further support pharmaceutical demand for high-precision rotary die equipment. Established production infrastructure and ongoing replacement of aging machines reinforce the segment's leading position. Pharmaceutical manufacturers also require controlled production processes to maintain consistent product quality across high-volume manufacturing operations.

Nutraceuticals represent the fastest-growing application, driven by rising global demand for vitamins, omega-3 supplements, and functional health products. Growing consumer focus on preventive health and immunity support is encouraging supplement brands to expand their soft gel product portfolios. This demand is supporting both branded manufacturers and contract producers in adding dedicated nutraceutical encapsulation capacity across established and emerging markets. Expanding private-label supplement production and broader product availability are further increasing equipment requirements. Manufacturers are adding flexible encapsulation lines to accommodate diverse formulations, shorter production runs, and increasing production volumes.

North America Soft Gel Encapsulation Machine Market Trends and Insights

North America is expected to hold about 28% share of the soft gel encapsulation machine market in 2026, supported by a mature pharmaceutical industry and well-established dietary supplement market. Manufacturers in the region are prioritizing equipment upgrades that improve batch traceability, process control, and compliance with stringent quality standards. Strong consumer demand for vitamins, omega-3 supplements, and functional health products continues to support equipment replacement and capacity expansion. North America is expected to see continued investment in automation as manufacturers respond to rising private-label supplement production and increasing demand for efficient, high-throughput operations. Contract manufacturers are also upgrading equipment to improve production consistency and accommodate broader supplement portfolios.

U.S. Soft Gel Encapsulation Machine Market Size

The U.S. accounts for 88% of North American soft gel encapsulation machine market revenue, supported by extensive pharmaceutical manufacturing and one of the world's largest dietary supplement industries. Strong demand from contract manufacturers serving private-label supplement brands is supporting continued investment in encapsulation equipment. Manufacturers are also replacing older systems with automated machines capable of higher throughput, improved process control, and consistent product quality. The country's equipment base is expected to continue modernizing as pharmaceutical and nutraceutical producers increase automation and production efficiency. Rising supplement consumption and expanding contract manufacturing capacity are creating additional opportunities for equipment suppliers.

Europe Soft Gel Encapsulation Machine Market Trends and Insights

Europe is projected to hold a 25% share of the soft gel encapsulation machine market in 2026, supported by stringent pharmaceutical manufacturing regulations and a well-developed nutraceutical sector. Manufacturers across the region are upgrading equipment to meet quality, hygiene, and process-control requirements while improving production efficiency. Demand for cosmetic and food-grade soft gel products is also supporting investment in specialized encapsulation systems. Europe is expected to experience continued equipment modernization as manufacturers balance regulatory requirements with increasing automation needs. Established pharmaceutical production and expanding nutraceutical applications are sustaining replacement demand for precision encapsulation equipment across major manufacturing markets.

Germany Soft Gel Encapsulation Machine Market Size

Germany accounts for around 32% of European soft gel encapsulation machine market revenue, supported by its strong pharmaceutical manufacturing base and advanced engineering capabilities. Domestic demand for precision equipment is reinforced by established pharmaceutical producers requiring consistent output and stringent process control. Manufacturers are also upgrading production systems to improve automation, operating efficiency, and compliance with quality requirements. Germany is expected to remain an important regional market as producers transition toward more automated encapsulation processes. Continued pharmaceutical and nutraceutical production is supporting investment in modern soft gel equipment.

U.K. Soft Gel Encapsulation Machine Market Size

The U.K. is anticipated to hold a substantial share of the European market in 2026, supported by a growing nutraceutical sector and established pharmaceutical manufacturing activity. Rising consumer demand for vitamins and functional supplements is encouraging manufacturers to expand soft gel production capacity. Contract manufacturers are also increasing equipment investment to support private-label supplement production and export-oriented operations. The market is expected to grow gradually as contract manufacturers expand capacity and adopt more automated production systems. Equipment modernization is further supporting consistent output, process control, and production efficiency across pharmaceutical and nutraceutical facilities.

France Soft Gel Encapsulation Machine Market Size

France is projected to hold a considerable share of the European market in 2026, supported by an established pharmaceutical and cosmetics manufacturing base. Growing demand for soft gel formats in dermo-cosmetic, pharmaceutical, and nutraceutical products is encouraging equipment upgrades among domestic manufacturers. Producers are expanding product portfolios while improving production efficiency and consistency through modern encapsulation systems. France is expected to see continued equipment demand as manufacturers diversify soft gel applications beyond traditional pharmaceutical products. Rising demand for functional supplements and specialized cosmetic formulations is further supporting investment in flexible encapsulation equipment.

Asia Pacific Soft Gel Encapsulation Machine Market Trends & Insights

Asia Pacific is expected to lead the global soft gel encapsulation machine market, holding around 42% share in 2026. Expanding pharmaceutical and nutraceutical manufacturing bases in China and India, supported by growing contract manufacturing activity, are driving strong equipment demand. Increasing local production of vitamins, supplements, and pharmaceutical products for domestic and export markets is encouraging manufacturers to add automated and high-throughput encapsulation lines. Asia Pacific is expected to strengthen its position as a major manufacturing hub for global soft gel supply chains as production capacity and outsourcing activity expand. Increasing manufacturing volumes are also supporting equipment modernization across major regional markets.

China Soft Gel Encapsulation Machine Market Size

China accounts for around 48% of Asia Pacific soft gel encapsulation machine market revenue, supported by its large base of nutraceutical and generic pharmaceutical manufacturers. Rising domestic supplement consumption and strong exports to North America and Europe are supporting continued investment in automated production lines. Manufacturers are expanding capacity to meet demand for vitamins, functional supplements, and pharmaceutical products across domestic and international markets. China's market is expected to expand as local producers increase production capacity and strengthen their role in global nutraceutical supply chains. Equipment modernization is further supporting higher throughput, process consistency, and production efficiency across large manufacturing facilities.

India Soft Gel Encapsulation Machine Market Size

India is projected to hold a significant share of the Asia Pacific market in 2026, supported by its large generic pharmaceutical industry and expanding nutraceutical production and exports. Rising domestic demand for affordable vitamins and supplements is encouraging manufacturers to add medium- and large-scale encapsulation lines. Contract manufacturers are also expanding production capabilities to serve domestic and international nutraceutical brands. India's market is expected to grow as manufacturers increase capacity and adopt more automated encapsulation equipment. Rising pharmaceutical output and broader availability of supplement products are further supporting demand for machines capable of consistent, high-volume soft gel production.

Japan Soft Gel Encapsulation Machine Market Size

Japan is anticipated to hold a notable share of the Asia Pacific soft gel encapsulation machine market in 2026, supported by its established pharmaceutical industry and strong demand for functional health products. Japanese manufacturers prioritize precision equipment capable of producing consistent, high-quality soft gels for domestic and export markets. Demand is also supported by continued development of specialized pharmaceutical, nutraceutical, and functional health products. Japan is expected to record modest but consistent growth as manufacturers invest in product innovation and equipment modernization. Upgraded encapsulation systems are supporting stringent production standards, process consistency, and efficient output across pharmaceutical and nutraceutical facilities.

The global soft gel encapsulation machine market remains moderately fragmented, with competition centered on engineering precision, machine reliability, gelatin handling, and after-sales service. Established equipment makers focus on high-performance systems for pharmaceutical and nutraceutical manufacturers requiring consistent output, precise dosing, and stable production. Smaller regional players compete mainly on price, particularly in manual and semi-automatic equipment. This creates a clear split between premium systems and cost-focused machines serving smaller production facilities across developing markets.

Leading companies are investing in automation, digital monitoring, and modular designs to support contract manufacturers handling multiple product formats. Strong engineering capability remains a key competitive factor, while new entrants mainly target cost-sensitive applications rather than high-throughput equipment.

Key Industry Developments

• In March 2025, ACG expanded its capsule and encapsulation equipment manufacturing capacity to support rising nutraceutical demand across Asia and North America. The expansion strengthens its production capabilities and enables the company to address growing requirements for automated and high-throughput encapsulation systems.
• In September 2024, Romaco Group introduced upgraded soft gel encapsulation systems featuring enhanced digital process monitoring for pharmaceutical manufacturers. The upgraded systems support closer process control, improve production visibility, and help manufacturers maintain consistent operating conditions during pharmaceutical soft gel production.
• In January 2024, IMA S.p.A. strengthened its life sciences equipment portfolio through continued investment in automated fill-finish and encapsulation technology. The investment supports broader automation capabilities and enables pharmaceutical manufacturers to improve production efficiency, process consistency, and equipment integration across manufacturing operations.